CUOG 2023 Research Grant COMPETITION ($50,000):

CUOG / UNIVERSITY OF TORONTO UROLOGIC ONCOLOGY PROGRAM COMMITMENT WITH ASTELLAS

PHARMA RESEARCH GRANT PROGRAM

3 Awards each in the amount of $50,000

Grant Recipients:

CUOG MEMBER GRANT RECIPIENT:             Peter Black

Title: Urothelial Cancer Screening in Individuals with Lynch Syndrome Using a Urine
Tumor DNA Panel: LS-URO Clinical Trial

CUOG MEMBER GRANT RECIPIENT:             Wes Kassouf

Title: Relevance of antibody-mediated selection of the urinary microbiome in the
response to bladder-sparing therapy in muscle-invasive bladder cancer.

CUOG MEMBER GRANT RECIPIENT:             Robert Sabbagh
Title: The gut-prostate axis in the pathogenesis of prostate cancer

 

 


CUOG 2023 Research Grant COMPETITION ($10,000):

CUOG / UNIVERSITY OF TORONTO UROLOGIC ONCOLOGY PROGRAM COMMITMENT WITH ASTELLAS

PHARMA RESEARCH GRANT PROGRAM

5 AWARDS each in the amount of $10,000

GRANT RECIPIENTS:

CUOG SUPERVISOR:              Robert Hamilton             Grant Recipient:   Ahmad Mousa

Title: Primary Retroperitoneal Lymph Dissection for Metastatic Nonseminomatous Germ

Cell Tumors: Review of Oncologic Outcomes and the Role of Adjuvant

Chemotherapy

 

CUOG SUPERVISOR:              Laurence Klotz               Grant Recipient:    Ravi Kumar

Title: Significance of MR visibility vs invisibility in a large active surveillance cohort

 

CUOG SUPERVISOR:              Ricardo Rendon             Grant Recipient:   Martha Foley

Title: The kinetics of prostate specific antigen (PSA) in advanced prostate cancer
patients while receiving treatment: A retrospective chart review

 

CUOG SUPERVISOR:              Eric Vigneault                 Grant Recipient:   Maimouna Diarra

Title: The association of circulating tumor DNA with tumor control and toxicity in prostate
cancer patients treated with EBRT and HDR brachytherapy boost

 

CUOG SUPERVISOR:              Christopher Wallis          Grant Recipient:   David Dan Nguyen

Title: Evaluating the Association of Marginalization and Socioeconomic Status with
Access to Androgen-Deprivation Therapy Intensification in Ontarians with de novo
Metastatic Prostate Cancer